INZIRQO (HYDROCHLOROTHIAZIDE) — FDA Approval NDA219141 (NOVITIUM PHARMA)
INZIRQO (HYDROCHLOROTHIAZIDE) — FDA Approval NDA219141 (NOVITIUM PHARMA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: INZIRQO; Active ingredients: HYDROCHLOROTHIAZIDE; Application number: NDA219141.
| Brand name | INZIRQO |
|---|---|
| Active ingredients | HYDROCHLOROTHIAZIDE |
| Application number | NDA219141 |
| Sponsor | NOVITIUM PHARMA |
| Dosage form | FOR SUSPENSION |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20250128 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →